ASU's Biodesign Institute Wins $30M DoD Contract for Immunosignature-Based Pathogen Detection Chip | GenomeWeb

This story originally ran on April 26.

Arizona State University's Biodesign Institute has won a four-year, $30.7 million contract from the US Department of Defense's Defense Threat Reduction Agency to build a prototype of a proteomics-based health monitoring chip.

The project aims to package immunosignaturing technology developed in the lab of Stephen Johnston, director of the institute's Center for Innovations in Medicine, into devices that can be used in the field for monitoring subjects' health and early detection of pathogen infection.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.